Aurinia Pharmaceuticals Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
AUPH Nasdaq 2836 www.auriniapharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aurinia Pharmaceuticals Inc.

Specific Biologics Welcomes Accomplished Biotechnology Leader Dr. Richard Glickman to its Board of Directors - Dec 16th, 2025 8:00 am
Assessing Aurinia Pharmaceuticals After Its 80% 2025 Surge and Lupus Nephritis Momentum - Dec 15th, 2025 1:08 am
Are Medical Stocks Lagging Aurinia Pharmaceuticals (AUPH) This Year? - Dec 10th, 2025 7:40 am
What Makes Aurinia Pharmaceuticals (AUPH) a Strong Momentum Stock: Buy Now? - Dec 5th, 2025 10:00 am
Aurinia Raises Guidance and Shares Are Surging— Is This Why a Major Investor Just Boosted Its Stake? - Dec 2nd, 2025 2:21 pm
Implied Volatility Surging for Aurinia Pharmaceuticals Stock Options - Dec 2nd, 2025 8:15 am
Is Aurinia Pharmaceuticals Still a Good Value After 83.8% YTD Surge? - Nov 30th, 2025 8:10 pm
A Look at Aurinia Pharmaceuticals (NasdaqGM:AUPH) Valuation After Recent Share Price Surge - Nov 30th, 2025 4:10 pm
Rigel Pharmaceuticals, Inc. (RIGL) Hit a 52 Week High, Can the Run Continue? - Nov 27th, 2025 7:15 am
First Look at Roche/Genentech’s Gazyva Shows Strong Early Enthusiasm in Lupus Nephritis Launch, According to Spherix Global Insights - Nov 19th, 2025 1:19 pm
Vera Therapeutics Stock Earns RS Rating Upgrade - Nov 18th, 2025 12:19 pm
Edgewise Therapeutics Stock Earns RS Rating Upgrade - Nov 17th, 2025 11:17 am
Results: Aurinia Pharmaceuticals Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - Nov 8th, 2025 6:02 am
Can Aurinia (AUPH) Run Higher on Rising Earnings Estimates? - Nov 7th, 2025 10:20 am
Aurinia Pharmaceuticals (AUPH) Profitability Milestone Reinforces Bullish Growth and Valuation Narratives - Nov 5th, 2025 3:06 am
Aurinia Pharmaceuticals Inc (AUPH) Q3 2025 Earnings Call Highlights: Strong Lupkynis Sales and ... - Nov 4th, 2025 2:05 pm
Aurinia Pharmaceuticals (AUPH) Surpasses Q3 Earnings and Revenue Estimates - Nov 4th, 2025 5:10 am
Aurinia: Q3 Earnings Snapshot - Nov 4th, 2025 4:11 am
Aurinia Pharmaceuticals Reports Financial Results for the Three and Nine Months Ended September 30, 2025 and Provides Update on Recent Business Progress - Nov 4th, 2025 4:00 am
Sector Update: Health Care Stocks Decline in Afternoon Trading - Nov 3rd, 2025 11:59 am